Circle HealthPod Rapid Detection System

Circle HealthPod

COVID-19 Molecular Capsule Set

Anterior Nasal Swab and Specimen Capsule

Circle HealthPod App

The Circle HealthPod COVID-19 test and laboratory tests commonly known as PCR are molecular nucleic acid amplification tests (NAAT) that detect the SARS-CoV-2 virus genetic material. Other types of molecular tests are PCR, RT-PCR and LAMP. Molecular tests are more accurate than other methods such as antigen tests. The Circle HealthPod test uses isothermal nucleic acid amplification technology developed by University of Oxford professors that is an equivalent alternative amplification method to polymerase chain reaction (PCR).

The HealthPod COVID-19 test detects SARS-CoV-2 nucleic acid in nasal specimens. An anterior nasal swab method is used for sample collection. This method collects samples at the lower nasal, pain-free and a simple experience compared to the nasopharyngeal swab which is more invasive.

The Circle HealthPod is designed to be reusable and shared under both condition below:

The Circle HealthPod is designed to be used safely after a positive result has been detected, as the collected sample is securely locked within the Specimen Capsule. Cleaning and disinfection procedures are suggested:

Circle HealthPod is designed to perform in-vitro diagnostic testing for infectious diseases. Our first, fully-validated test is for COVID-19 and development has started for future tests such as for Influenza and STDs.

Molecular tests detect genetic material – the RNA (ribonucleic acid) – specifically to SARS-CoV-2. Molecular tests amplify bits of viral RNA so that the presence of the viral genetic material can be detected. This can also be referred to as nucleic acid amplification test (NAAT). The procedure begins by taking a sample from a potentially infected person’s nose where a virus might be found. If SARS-CoV-2 is present in the sample, then even low levels of viral genetic material can be amplified into millions of copies detected during a molecular diagnostic assay. If a person is infected, the viral RNA will be detected and produces a positive test result; if a person is not infected, no viral RNA will be copied or detected, which will produce a negative test result. Amplifying the signal allows for even small amounts of virus to be detected.

The Circle HealthPod is designed to be reusable and shared under both condition below:

The Circle HealthPod is designed to be used up to more than 1000 times. The capsule set has a shelf life for 6 months when stored properly.

The Circle HealthPod is designed to be used safely after a positive result has been detected, as the collected sample is securely locked within the Specimen Capsule. Cleaning and disinfection procedures are suggested:

Circle HealthPod is designed to perform in-vitro diagnostic testing for infectious diseases. Our first, fully-validated test is for COVID-19 and development has started for future tests such as for Influenza and STDs.

A test can be done with or without the connection to a smartphone. The registration for individual accounts on smartphones is to allow access to past result records from users and to also share results. The test results can also be detected on the Circle Healthpod itself via the LED lights which will show positive, negative and invalid status.

Each Circle HealthPod can be connected to a single smartphone at one time, it is to ensure the results are secure.

Molecular tests detect genetic material – the RNA (ribonucleic acid) – specifically to SARS-CoV-2. Molecular tests amplify bits of viral RNA so that the presence of the viral genetic material can be detected. This can also be referred to as nucleic acid amplification test (NAAT). The procedure begins by taking a sample from a potentially infected person’s nose where a virus might be found. If SARS-CoV-2 is present in the sample, then even low levels of viral genetic material can be amplified into millions of copies detected during a molecular diagnostic assay. If a person is infected, the viral RNA will be detected and produces a positive test result; if a person is not infected, no viral RNA will be copied or detected, which will produce a negative test result. Amplifying the signal allows for even small amounts of virus to be detected.

Molecular tests are 500x more accurate than other methods such as antigen tests. Isothermal loop-mediated nucleic acid amplification technology (LAMP) is used for the molecular amplification reaction that is an equivalent alternative amplification method to polymerase chain reaction (PCR). Molecular tests determine if you have a current infection.

Antigen test detects specific proteins on the surface of the SARS-CoV-2 virus. Antigen tests also determine if you have a current infection, but are generally less sensitive than molecular tests.

Antibody test detects the presence of antibodies to the SARS-CoV-2 virus, which reflects the body’s immune response. Antibody tests determine if you had a past infection of COVID-19.